Speakers:

Paolo Balboni

President
European Privacy Association

Dr Ana Silvia Nita

Group Leader, Global Regulatory Affairs CMC
Roche Pharmaceuticals (Switzerland)

Mario Bertazzoli M.D.

Director, Head of Corporate Drug Safety
Helsinn Healthcare (Switzerland)

Ingrid Vandenborre

Partner
Skadden (Belgium)

Strategies for Avoiding Anti-Competitive Conduct

September 28, 2016 11:30 am

Dr Alexander Natz

Secretary General
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) (Belgium)

Nancy Pei

Partner
Smart & Biggar/Fetherstonhaugh (Canada)

Cecil Nick

Vice President
PAREXEL Consulting

Nicola Dagg (United Kingdom)

Partner
Allen & Overy

Lindsey Kent

European Patent Counsel
Eli Lilly (UK)

Dr Zubair Hussain

Independent Strategic Regulatory Consultant

Professor Sir Michael Rawlins

Chair
The Medicines and Healthcare Products Regulatory Agency (UK)

Elisabethann Wright

Partner
Hogan Lovells (Brussels)

Dr Christian B Fulda

Partner
Jones Day

Opening Remarks from the Chair

September 28, 2016 9:00 am

Laetitia Szaller

Associate General Counsel Business Development and Technical Operations
UCB Pharma

Strategies for Avoiding Anti-Competitive Conduct

September 28, 2016 11:30 am

Peter Bogaert

Partner
Covington & Burling LLP (Brussels)

Colin Kavanagh

Partner and Head of Life Sciences
Arthur Cox

Opening Remarks from the Chair

September 27, 2016 10:00 am